Rajavithi Health Promotion Project (Population Base Cohort)
This study is currently recruiting participants.
(see Contacts and Locations)
Verified August 2008 by Rajavithi Hospital
Sponsor:
Rajavithi Hospital
Collaborator:
U.S. Department of Education
Information provided by:
Rajavithi Hospital
ClinicalTrials.gov Identifier:
NCT00368095
First received: August 23, 2006
Last updated: August 2, 2008
Last verified: August 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Metabolic Syndrome (hypertension, diabetes mellitus, obesity, cerebrovascular-cardiovascular disease) In Community Survey was performed in central Bangkok.
Prospective Cohort and intensive educated intervention (health promotion program in specific high risk groups) were performed. The aim of the study is to identify high risk patients who can develop serious complications from metabolic syndrome. An analysis of health outcomes in multiple dimensions will be performed.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Mellitus Hypertension Dyslipidemia Obesity Cardiovascular Disease Coronary Artery Disease |
Behavioral: Intensive Education for Metabolic Syndrome Patients |
Phase 4 |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | The Rajavithi Prospective Cohort Study on Community's Member Health (HPH-Cohort Study) |
Resource links provided by NLM:
Further study details as provided by Rajavithi Hospital:
Biospecimen Retention: Samples With DNA
Human Genetic Bank will be storaged in Biomolecular center Rajavithi Hospital for determine the gene that influence the specific disease in the population
| Estimated Enrollment: | 2000 |
| Study Start Date: | August 2006 |
| Estimated Study Completion Date: | August 2016 |
Intervention Details:
-
Behavioral: Intensive Education for Metabolic Syndrome Patients
Excercise, Intensive diatary program
Other Name: Patient with Metabolic Syndrome will be advised fro improve health status and genetic test will be apply
Eligibility| Ages Eligible for Study: | 16 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
General population in Dindang destrict Bangkok
Criteria
Inclusion Criteria:
- Age 16 years or more
- Informed consent
- Living in selected community (Health Promotion area of Rajavithi Hospital)
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00368095
Please refer to this study by its ClinicalTrials.gov identifier: NCT00368095
Contacts
| Contact: Subsai Kongsaengdao, M.D. | 66-6-6596159 | skhongsa@gmail.com |
Locations
| Thailand | |
| Rajavithi Hospital | Recruiting |
| Bangkok, Thailand | |
Sponsors and Collaborators
Rajavithi Hospital
U.S. Department of Education
Investigators
| Principal Investigator: | Subsai Kongsaengdao | Rajavithi Hospital | |
| Study Director: | Piyathida Harnsomboonrana, M.D. | Rajavithi Hospital | |
| Study Chair: | Wilai Pauvilai, M.D. | Rajavithi Hospital |
More Information
No publications provided
| Responsible Party: | Rajavithi Hospital |
| ClinicalTrials.gov Identifier: | NCT00368095 History of Changes |
| Other Study ID Numbers: | RVH_CER_004 |
| Study First Received: | August 23, 2006 |
| Last Updated: | August 2, 2008 |
| Health Authority: | Thailand: Ministry of Public Health |
Keywords provided by Rajavithi Hospital:
|
DM HT Dyslipidemia Obesity Cardiovascular disease |
Cerebrovascular disease Myocardial infarction stroke Metabolic syndrome CVD-CAD |
Additional relevant MeSH terms:
|
Glucose Metabolism Disorders Lipid Metabolism Disorders Metabolic Diseases Cardiovascular Diseases Coronary Artery Disease Coronary Disease Diabetes Mellitus Dyslipidemias Hypertension Myocardial Ischemia Obesity |
Arterial Occlusive Diseases Arteriosclerosis Body Weight Endocrine System Diseases Heart Diseases Nutrition Disorders Overnutrition Overweight Signs and Symptoms Vascular Diseases |
ClinicalTrials.gov processed this record on February 26, 2015